Merck and Co. Inc., the largest U.S. pharmaceutical company, transferred its genetically engineered hepatitis B vaccine technology to China in 1989. 1989年,美国最大的制药公司默克公司时任董事会主席、总裁罗伊·瓦格洛斯博士决定将重组乙肝疫苗技术转让给中国。 This was the decision of its former preside...
Merck & Co. Marketing Pfizer enlists Elizabeth Banks for pneumococcal vaccine push To strike a pitch-perfect tone with Gen X, Pfizer has recruited Elizabeth Banks as the face of a new awareness campaign for pneumococcal vaccination. Andrea ParkMar 19, 2025 3:20pm...
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
正确答案:increase the risk of contracting the virus解析:根据题干关键词vaccine made by Merck & Co定位到原文最后一段最后一句:Another trial by Merck & Co.of a different vaccine was halted prematurely in 2007 when researchers found that the vaccine might increase the risk of contracting the virus....
Merck & Co is also conducting clinical trials to evaluate two COVID-19 vaccine candidates: V590, being developed through a collaboration with IAVI, which utilizes a recombinant vesicular stomatitis vector, and V591 which uses a measles virus as a vector.Image...
MerckVaccines is a site for health care professionals to find information about Merck's vaccine portfolio, as well as vaccine tools and resources.
Reports on the expectation of Merck & Co. Inc. on the possibility of experimental human papilloma virus vaccine Gardasil to save its damaged reputation in the U.S. Assurance of the saving thousands of li...
Merck & Co. Inc. SEC filings breakout by MarketWatch. View the MRK U.S. Securities and Exchange Commission reporting information.
Evaluation of a bovine-human rotavirus reassortant vaccine in infants. J Infect Dis 1993 Dec; 168: 1598–9 Article PubMed CAS Google Scholar Download references Rights and permissions Reprints and permissions About this article Cite this article Rotavirus W179-9 Vaccine (Merck and Co). Drugs ...
Merck and Moderna's mRNA cancer vaccine aces its first effic... The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. ...